High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma. - Wikidata - awgldk - TriplyDB

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

http://www.wikidata.org/entity/Q37385234

about

ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors ALK-rearrangements and testing methods in non-small cell lung cancer: a review Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.Identification of ALK gene alterations in urothelial carcinoma.MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib.ALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor.Targeting Autophagy in ALK-Associated Cancers.PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.Targeting ALK in pediatric RMS does not induce antitumor activity in vivo.

P2860

Q26775347-11A20239-F316-45D1-9829-A20AC188E5A8 Q28546245-503A0825-6038-46A5-A8DD-D6BB1A807403 Q33776835-17E758D3-8A37-4FF1-8C2D-4BEBE8EC5FD2 Q33800135-A60533C9-54F8-4C64-A6B9-CB106F49B113 Q33989002-7ACD898F-ABAA-469F-BC3E-3CB0E7D3CB0F Q35542078-DE15956C-FF27-44FF-AB2D-DB51C41A3282 Q37644788-D9B6ABA7-3744-4F1A-9FBF-4B0DE0713F57 Q38829675-EFD48C44-4A9E-45FB-AADB-0C7D9D97DCD0 Q47164935-F20CB8B0-B3DE-4A33-9AE0-42A34E6213B4 Q47712911-770B5B14-13B6-4554-A434-367078E0C260 Q49545616-59A94481-93F2-4405-9EE6-2FC3DC42A123 Q54977242-6FDB6774-841F-47F6-A9A8-FEDEEE4238BD Q54977430-C3ECEFFB-BDEA-468B-B853-866E484541E2

P2860

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

http://www.wikidata.org/entity/Q37385234

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@en

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@nl

type

label

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@en

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@nl

prefLabel

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@en

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

@nl

P1433

Q37385234-ADE95F3C-9727-4ADD-B3DD-F6B9B327BDC9

P1476

Q37385234-9F941547-C0CD-48D0-89E6-64D1A2152D15

P2093

Q37385234-4D0A0CA3-A574-4F47-87BC-E06F698A3306

Q37385234-968BAB85-3C27-4282-9962-62AF82749AAC

Q37385234-9E3B9402-E822-4914-80F7-53093DA91DFE

Q37385234-BC2F7CAD-F24A-4F7D-9AD5-5A4E70A54A28

Q37385234-DA7A7DE0-977A-4098-BD5E-59918A885240

P2860

Q37385234-0366BADE-6DB2-4A5E-8BB8-FBE0C444E3D8

Q37385234-095A07A6-1048-44BC-91AA-D6F4DDB80BCC

Q37385234-0F92A0ED-15F0-47BB-8468-D7E9843899A6

Q37385234-16968F6D-9B3A-4BED-B878-BEDBAD287FBE

Q37385234-1AC3619E-46C1-43B9-981A-EAD003D1377A

Q37385234-1C8F62A0-6039-47C5-A7E8-B5323A04937F

Q37385234-1DC8E9BF-00AC-4D20-9CA0-942A5907057A

Q37385234-1F12F674-D0E0-4AF4-91D9-B4C77ECB532C

Q37385234-3E2063FA-9DAA-421B-B9A2-54EF8EE47893

Q37385234-44A7C349-340A-4413-88E9-3B64194F290C

P2888

Q37385234-0F59D455-FB3A-4397-9F95-8423004ACA8C

P304

Q37385234-9C00662C-5CDC-46D3-B3CF-930DC2AB465F

P31

Q37385234-ACDB2A8D-27E0-4FC2-85B1-18A43B26F16D

P356

Q37385234-C09BEE07-C439-45E8-8910-6A856A857C23

P407

Q37385234-509E7A46-720E-4775-91B2-871F65BD5806

P433

Q37385234-EB5C4070-B2E4-4D2A-A583-7B7C2AF3C26D

P478

Q37385234-2DAEB7C7-9A5A-4E6C-B3B7-152FB5ED233E

P50

Q37385234-E3587440-ECDA-40C5-B46F-9DE7B9A2B5D2

P577

Q37385234-71C262A5-4DE4-4761-ACD2-138FA6D1F382

P5875

Q37385234-3BDDF542-1672-4784-8A37-304B89B819FE

P698

Q37385234-514D4BCD-9E96-4546-A48E-E3783990209F

P932

Q37385234-8919E0B3-F884-4A00-961A-2989E5108A61

P356

P1433

British Journal of Cancer

P1476

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma

@en

P2093

A Rosolen

http://www.w3.org/2001/XMLSchema#string

A Zin

http://www.w3.org/2001/XMLSchema#string

B Pawel

http://www.w3.org/2001/XMLSchema#string

P Bonvini

http://www.w3.org/2001/XMLSchema#string

R Alaggio

http://www.w3.org/2001/XMLSchema#string

P2860

The protein kinase complement of the human genome

Identification of ALK as a major familial neuroblastoma predisposition gene

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamy

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma.

ALK protein expression in rhabdomyosarcomas.

Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.

Mechanisms of sarcoma development.

P2888

P304

3084-3091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.653

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258034162

http://www.w3.org/2001/XMLSchema#string

P698

24149177

http://www.w3.org/2001/XMLSchema#string

P932

3859940

http://www.w3.org/2001/XMLSchema#string